Member Info for shandypants2

steady climb continues. 2p short term target?

Found this - 50m people suffer from dementia. Potential huge new market for IMMO

http://www.ladbible.com/news/technology-doctors-are-using-virtual-reality-to-treat-people-with-dementia-20190827

results day 24th Sept - put it in the diary.

Has the buying already commenced - up 5% today?

Belgrano - "SOH has never let us down on his promises" is part of the problem surely. He has never made any promises as such as has never given any financial projection for the company. So we sign 44 contracts and have to guess how much money they might generate and when.
I think people are getting inpatient with both him and the company - we have been told about the hockey stick growth of revenues yet have no idea when/if this may occur.
Similarly house broker FinnCap get heavily criticised on here but surely they are only as good as the info they are given by the company.
Not saying SOH is a bad CEO just pointing out it's easy not to break any promises when you either don't make any or give such low ball figures it's difficult to not hit them. For example - if we hit it, is £1m revenue for full year really that good?

are you sure, only just announced 1/2 year. UPGS is next Monday - have you got the 2 confused??

I have 890,000. Add them on!

https://rootsdoubleeffect.com

Roots just sent me a 20% off code - COMEBACK20

Hopefully will work for other customers too. Feel free to forward

Hi, good question.

Pretty sure they won't go for anymore funding.

I think expansion will be a combination of
1) using recent £10m fundraise
2) uses profits generated - could be £5m EBITA this year
3) using leasehold rather than purchase as an option (as they did in Vienna last year) - so have a mix of owned and leased properties
4) potentially and I think this is a last resort taking on a commercial mortgage

All IMHO of course

Great tie up and agree hopefully could expand this to gin and vodka. Need to move away from being a 1 product company if this is to grow

Deez - share price was 0.16p in Sept hast year (before delayed SS). Since then we've had a placing at 0.015p which resulted in a c50% share dilution so comparisons in share price are a bit misleading. Value of company may be a better way to go.

Think we were c£10m at peak last year.

Turner Pope SP valuation is 0.095p based on average between discounted cashflow value of 0.13p and peer based comparison of 0.06.

Obviously if NPV increases, which should happen if mineralisation is upgraded, then these valuations will rise

give it a rest Greg - all LTHs got burnt when HC sold last year - let it go and move on, if only for your own health.

HC still owns 27% on the company and hasn't sold since, despite your regular comments that he is still selling.

The last update was positive and so should the 17th Sept one - I know this doesn't fit with your agenda but so be it.

Chris - 1 agree there may be a RNS on Wednesday to coincide with the conference but why also today and tomorrow?

We all want the share price to rise but no need to make things up

Whilst i think Opti has great potential and there is clear need for the products as this definitely benefits gut health, cholesterol and sugar cravings to name but 3 areas the lack of revenue growth is a concern to be.

However, these results are poor and makes me question the business strategy. Similarly countering that SOH has always given accurate revenue forecasts, the year was always H2 weighted, accounting changes, cash is fine is missing the point.

This was a c£100m company less than a year ago (still over £40m now) so significant growth has been factored in as current revenues were minimal. If a company isn't growing quickly then that is a massive concern to me.

Let look at the facts. 44 deals since mid 2017 - now mid 2019 and barely any are producing revenue - yes I know many were signed in last year etc and these things take time but this is poor.
Even if £1m revenue is achieved this is still loss making and the H2 figures will include some one off payments.
The model of deals with no upfront payment whilst keeping costs for Opti at near zero means delays are inevitable and out side SOHs control.
Using H1 statement to talk about 2020 revenues is clearly trying to distract from the poor figures.

SBTX share sale wasn't just about potential acquisition it was also keeping the lights on - it says it in the RNS - here:
a Company disposed of over £250,000 of its shares in SBTX reducing its holding from 38.9% to 37.6% to explore a potential acquisition opportunity and providing sufficient funds to see through existing plans.

I remember taking to Christina at a trade fair 6 or so months ago. I thought she was a bit of a SOH clone to be honest. Really engaging etc but felt SOHs strategy was 100% the way to go - i.e no UK shop presence, no upfront payments etc.
Now she has gone - seems more of an admission that SOH approach is thus far not delivering.

Good luck to all LTH but IMHO nothing much will happen here for next 5 months or so

can't believe this isn't rising steadily ahead of results in just over a week's time.

Seems very cheap for a company with £122m revenue and profits that will be above the £9m previously stated.

Still think this could hit £1 in next month

as per last couple of updates I can see a gradual increase in interest and share price over the next couple of weeks as we approach results day ( I think this is 17th Sept).
Will be surprised to see this below £1 before results are announced. Afterwards who knows.

Someone has just bought 10,000 shares so perhaps that's the start

I really enjoy Elrico's blogs etc but do object a little when it is inferred 'we don't get it'.

If YE guidance is £1m even with H2 weighted would expect £300k in H1 - we got c50% of this. Furthermore as c 50% of this was via the online store then it is clear that only a few of the 44 deals are actually generating any income.
This has worried people.

Similarly if cash is so strong why sell some SBTX shares to boost the cash position?

With so little revenue coming in from these deals when will this hockey effort on revenue occur? 2020, 21 or 22 - the date keeps moving back.

This is a great product(s) but we need deals that have upfront payments and short term commitments. Without this how can revenue guidance ever be estimated - and as SOH rarely commits to any guidance he will never miss a target.

this company is valued at c£50m - at some point revenues need to justify this valuation

yes same price ranges on My Lotus website too, although Boots still £349.

No news on revenues which is a concern as this company lost £2.8m last year and had to do a £2m raise in April - that money may soon be gone.

great product, but PR and marketing is lacking.

The $300m at YE is £246m at today's exchange rate.
Even with a dividend and share buy back cash in bank will have risen in last 8 months.

Current GKP valuation is £536m - so potentially 50% of the current valuation is cash.

so how will they fund the next 18 months? Sell more SBTX shares?
Surely doing deals with an upfront payment is the way to go - shows commitment on both sides.

I wasn't expecting great revenues but was led to believe (by SOH) that we were covering costs most months- so that's c£100k a month - not over 6 months.

Whilst I understand that these deals focus all the costs on the supplier maybe OPTI need to start getting some upfront payments in lieu of future royalties. This also ensures commitment from the companies - at the moment there is no time pressure on them to deliver and so OPTI is suffering.

50p is coming based on current position IMHO